| Dr Keith Philip Pasichow, MD | |
|
1040 Broad St Ste 300, Shrewsbury, NJ 07702-9908 | |
| (732) 389-0066 | |
| (888) 487-1131 |
| Full Name | Dr Keith Philip Pasichow |
|---|---|
| Gender | Male |
| Speciality | Hospice/palliative Care |
| Experience | 14 Years |
| Location | 1040 Broad St Ste 300, Shrewsbury, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366754517 | NPI | - | NPPES |
| 04301277 | Medicaid | NY | |
| 0682136 | Medicaid | NJ | |
| 1035864390001 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Seasons Hospice & Palliative Care Of New Jersey Ll | Hamilton, NJ | Hospice |
| Monmouth Medical Center | Long branch, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Barnabas Health Medical Group Pc | 9537316955 | 558 |
News Archive
The upcoming expansion of Medicaid under the Affordable Care Act (ACA) won't lead physicians to reduce the number of new Medicaid patients they accept, suggests a study in the November issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug.
According to the consumer watchdog Public Citizen, the weight loss drugs Alli and Xenical should be removed from the market because of the growing risk of side effects that include liver damage, pancreatitis and kidney stones.
The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
The upcoming expansion of Medicaid under the Affordable Care Act (ACA) won't lead physicians to reduce the number of new Medicaid patients they accept, suggests a study in the November issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug.
According to the consumer watchdog Public Citizen, the weight loss drugs Alli and Xenical should be removed from the market because of the growing risk of side effects that include liver damage, pancreatitis and kidney stones.
The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Entity Name | Meridian Medical Group-specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942362587 PECOS PAC ID: 6507962206 Enrollment ID: O20070425000673 |
News Archive
The upcoming expansion of Medicaid under the Affordable Care Act (ACA) won't lead physicians to reduce the number of new Medicaid patients they accept, suggests a study in the November issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug.
According to the consumer watchdog Public Citizen, the weight loss drugs Alli and Xenical should be removed from the market because of the growing risk of side effects that include liver damage, pancreatitis and kidney stones.
The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
The upcoming expansion of Medicaid under the Affordable Care Act (ACA) won't lead physicians to reduce the number of new Medicaid patients they accept, suggests a study in the November issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug.
According to the consumer watchdog Public Citizen, the weight loss drugs Alli and Xenical should be removed from the market because of the growing risk of side effects that include liver damage, pancreatitis and kidney stones.
The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Entity Name | Tri-county Home And Hospice Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427419001 PECOS PAC ID: 3870884406 Enrollment ID: O20170612000597 |
News Archive
The upcoming expansion of Medicaid under the Affordable Care Act (ACA) won't lead physicians to reduce the number of new Medicaid patients they accept, suggests a study in the November issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug.
According to the consumer watchdog Public Citizen, the weight loss drugs Alli and Xenical should be removed from the market because of the growing risk of side effects that include liver damage, pancreatitis and kidney stones.
The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith Philip Pasichow, MD 4236 Pechin St, Philadelphia, PA 19128-5022 Ph: () - | Dr Keith Philip Pasichow, MD 1040 Broad St Ste 300, Shrewsbury, NJ 07702-9908 Ph: (732) 389-0066 |
News Archive
The upcoming expansion of Medicaid under the Affordable Care Act (ACA) won't lead physicians to reduce the number of new Medicaid patients they accept, suggests a study in the November issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Over 50 million people across the world suffer from epilepsy, making it the most common serious neurological disorder for which there is no cure. The causes for epilepsy are insufficiently understood with currently available treatments being sub-optimal and with a significant proportion of patients not responding
At a time when cancer drug prices are rising rapidly, an innovative new study provides the framework for establishing value-based pricing for all new oncology drugs entering the marketplace. Using a highly sophisticated economic model, researchers from Winship Cancer Institute of Emory University and Georgia Institute of Technology used an example of a new lung cancer drug.
According to the consumer watchdog Public Citizen, the weight loss drugs Alli and Xenical should be removed from the market because of the growing risk of side effects that include liver damage, pancreatitis and kidney stones.
The risk of both mortality and rehospitalization after an elective revascularization procedure for coronary artery disease is similar for people with and without Alzheimer's disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.
› Verified 7 days ago
Dr. Jacqueline Lopresti, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 655 Shrewsbury Ave, ., Shrewsbury, NJ 07702 Phone: 732-576-8850 Fax: 732-747-1468 | |
Dr. Jeffrey David Felzenberg, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 23 White St, Shrewsbury, NJ 07702 Phone: 732-747-1555 Fax: 732-741-8262 | |
Dr. Shahid Waseem Farooqui, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 White Rd, Ste.b, Shrewsbury, NJ 07702 Phone: 732-747-4723 Fax: 732-747-5998 | |
Amber Dessalines, APN Internal Medicine Medicare: Medicare Enrolled Practice Location: 170 Avenue At The Cmn Ste 2, Shrewsbury, NJ 07702 Phone: 732-747-6600 Fax: 732-747-6001 | |
Lizett A Marza, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Patterson Ave, Shrewsbury, NJ 07702 Phone: 732-747-4600 Fax: 732-219-1968 | |
Dr. Ravindran Thirunavu Rajaraman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 59 Avenue At The Cmn, Suite#105, Shrewsbury, NJ 07702 Phone: 732-544-8899 Fax: 732-544-9888 |